Showing results (471-480 of 757) with videos related to

Sort By:
Pageof 76
Journal of the American Heart Association|March 23, 2021
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME TrialJoão Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trialMuthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
Journal of Cardiology|April 25, 2013
Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacementHenrik Fox, Stefan Büttner, Katrin Hemmann, et al.
Kidney International|September 3, 2015
Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription ratesMarkus P Schneider, Silvia Hübner, Stephanie I Titze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 18, 2011
Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in EuropeMoniek W M van de Luijtgaarden, Marlies Noordzij, Vianda S Stel, et al.
Biochimica Et Biophysica Acta|September 21, 2010
Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapyMariëlle J van Breemen, Saskia M Rombach, Nick Dekker, et al.
Experimental Gerontology|October 2, 2015
Do telomeres have a higher plasticity than thought? Results from the German Chronic Kidney Disease (GCKD) study as a high-risk populationJulia Raschenberger, Barbara Kollerits, Stephanie Titze, et al.
Kidney International|March 22, 2026
A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney diseaseDavid Z I Cherney, Karen Bonefeld, Glenn Crater, et al.
European Journal of Heart Failure|April 16, 2023
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trialAbhinav Sharma, João Pedro Ferreira, Faiez Zannad, et al.
Brain Communications|May 16, 2024
Dorsal root ganglion magnetic resonance imaging biomarker correlations with pain in Fabry diseaseMagnus Schindehütte, Simon Weiner, Katharina Klug, et al.
Pageof 76